Wondfo Biotech SARS-CoV-2 COVID19 IgM/IgG antibody rapid test kit. The box of 20 test cassettes includes 20 disposable pipettes and one bottle of buffer solution for the full contents of the pack. Lancets and disinfectant wipes not included.
The Wondfo Biotech SARS-CoV-2 Antibody (lateral flow) rapid test kit is a Point of Care Test (PoCT) which requires a lancet prick of the finger to get a drop of blood, add 2 drops of reagent and you will get a result within 15 minutes (see attached Instructions For Use).
One of the advantages of rapid antibody tests is that the antibody response stays in the system long after the infection has cleared. The problem with molecular testing is that once the viral load in the body reduces, the tests become less accurate. Antibody tests are useful in screening for people who have been infected and developed antibodies but were asymptomatic. It is therefore a more flexible solution for community based screening. People’s autoimmune responses vary greatly therefore some people are symptomatic faster than others and some not symptomatic at all and therefore can be hidden carriers.
Serological assays are simple, cheap, rapid, easy to interpret, and practical to use for community COVID-19 testing.
| ARTG No: | # 333902 |
| Product Code: | COVID-19 Test Kits |
| CE Certified: | MDSAF Cert #QS6 058008 0029; TUV SUD America; CE Belgium |
| Units: | 20 COVID-19 Test Kits per Box |
| Quantity: | 10 Boxes per Carton |
| Inclusion in COVID-19 Test Kits: | 20 Test Cassettes; 1 bottle of reagent buffer; 20 disposable pipettes; |
| Contact for Purchase - Limited to medical professionals. | admin@GlobalHealthWorkz.com Mob: 0400 219 146 |
WHO has listed the Wondfo SARS-CoV-2 Antibody Test (Lateral Flow Method) W195 in the (EUL) Emergency Use List.
Wondfo Biotech SARS-CoV-2 Antibody Rapid Test Kits (PoCT) are only available for purchase by Medical Professionals. Contact Jill Tayler Jill@GlobalHealthWorkz.com for enquiries.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470698/
https://www.medrxiv.org/content/10.1101/2020.09.10.20192260v1
